查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1559024

結核病診斷市場：2024-2031年全球產業分析、規模、佔有率、成長、趨勢、預測

Tuberculosis Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 177 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research最近發布了一份關於全球結核病診斷市場的綜合報告，深入分析了關鍵市場動態，包括市場驅動因素、趨勢、機會和挑戰。這份詳細的報告揭示了預測期內的市場結構和成長潛力。

主要見解

  • 結核病診斷市場規模（2024年）：23億美元
  • 預測市場規模（2031年）：33億美元
  • 全球市場成長率（2024-2031年年複合成長率）：5.5%

結核病診斷市場-調查範圍：

結核病診斷包括目的是檢測和診斷結核病（世界上最致命的傳染病之一）的各種測試和工具。這些診斷在識別活動性和潛伏性結核病感染、指導治療和監測結核病傳播方面發揮重要作用。該市場的推動因素包括結核病患者的不斷上升、診斷技術的進步以及對早期診斷和治療的認識不斷增強。

市場驅動因素：

有幾個關鍵因素推動全球結核病診斷市場的成長。許多地區、特別是發展中國家的結核病發生率上升是一個重要的驅動因素。政府消除結核病的努力，加上世界衛生組織（WHO）等全球衛生組織的資助，推動對有效診斷解決方案的需求。分子診斷和即時檢測等技術進步也透過實現更快、更準確的疾病檢測來推動市場成長。對早期檢測以防止結核病傳播的日益重視也推動了先進診斷工具的採用。

市場限制因素：

儘管存在成長潛力，結核病診斷市場仍面臨一定的挑戰。關鍵的抑制因素之一是先進診斷技術的高成本，這在結核病最受歡迎的低收入和中等收入國家可能令人望而卻步。此外，農村和未開發地區醫療設施和診斷基礎設施不足也是市場成長的障礙。結核病診斷的複雜性以及需要訓練有素的衛生專業人員進行測試和解釋結果進一步限制了其在資源匱乏地區的採用。

市場機會：

結核病診斷市場提供了巨大的成長機會，特別是由於診斷工具和技術的不斷創新。開發具有成本效益、攜帶式且易於使用的診斷設備市場是在服務不足的地區擴大市場的重大機會。此外，日益採用數位健康解決方案和遠距醫療來進行遠距結核病診斷和監測也可以推動市場成長。診斷公司與醫療機構之間的策略聯盟可望加強研發，進一步提高結核病診斷能力。

本報告涵蓋的主要問題

  • 推動全球結核病診斷市場的關鍵因素是什麼？
  • 哪些地區和衛生系統對結核病診斷工具的需求最高？
  • 技術創新如何影響結核病診斷市場狀況？
  • 誰是結核病診斷市場競爭的主要參與者？
  • 全球結核病診斷市場的新趨勢和未來成長前景是什麼？

目錄

第1章 執行摘要

第2章 市場概述

  • 市場範圍與定義
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
    • 課題
    • 主要趨勢
  • 宏觀經濟因素
    • 全球 GDP 成長前景
    • 全球醫療支出展望
  • 新冠肺炎（COVID-19）影響分析
  • 預測因子 - 相關性和影響

第3章 附加價值見解

  • 產品採用率分析
  • 疾病流行病學
  • 監理狀況
  • 價值鏈分析
  • 主要交易和合併
  • PESTLE分析
  • 波特五力分析

第4章 全球結核病診斷市場展望：實績（2019-2023年）與預測（2024-2031年）

  • 全球結核病診斷市場展望：檢驗類型
    • 簡介/主要調查結果
    • 2019-2023年歷史市場規模（十億美元）分析，依檢驗類型
    • 2024-2031年目前市場規模（十億美元）的分析與預測，依檢驗類型
      • 核酸檢測
      • SMEAR顯微鏡檢查
      • 輻射測試
  • 市場吸引力分析：考試類型
  • 全球結核病診斷市場前景：最終用戶
    • 簡介/主要調查結果
    • 2019-2023年歷史市場規模（十億美元）分析，依最終用戶
    • 2024-2031目前市場規模（十億美元）的分析與預測，依最終用戶
      • 醫院/診所
      • 診斷中心
  • 市場吸引力分析：最終用戶

第5章 全球結核病診斷市場前景：地區

  • 2019-2023年過去市場規模（十億美元）分析，依地區
  • 2024-2031年當前市場規模（十億美元）分析和預測，依地區
    • 北美
    • 歐洲
    • 東亞
    • 南亞和大洋洲
    • 拉丁美洲
    • 中東、非洲
  • 市場吸引力分析：地區

第6章 北美結核病診斷市場展望：實績（2019-2023年）與預測（2024-2031年）

第7章 歐洲結核病診斷市場展望：實績（2019-2023年）和預測（2024-2031年）

第8章 東亞結核病診斷市場展望：實績（2019-2023年）與預測（2024-2031年）

第9章 南亞和大洋洲結核病診斷市場展望：實績（2019-2023年）和預測（2024-2031年）

第10章 拉丁美洲結核病診斷市場展望：實績（2019-2023年）和預測（2024-2031年）

第11章 中東和非洲結核病診斷市場展望：實績（2019-2023年）和預測（2024-2031年）

第12章 競爭態勢

  • 2023年市場佔有率分析
  • 市場結構
    • 依市場劃分的競爭強度圖
    • 競爭儀表板
  • 公司簡介（詳細資料 - 概述、財務狀況、策略、近期發展）
    • Abbott
    • QIAGEN
    • Thermo Fisher Scientific Inc.
    • BD
    • F. Hoffmann-La Roche AG
    • Hologic, Inc.
    • Cepheid
    • DiaSorin SpA
    • Hain Lifescience GmbH
    • Oxford Immunotec
    • 其他

第13章 附錄

  • 調查方法
  • 調查假設
  • 首字母縮寫詞和縮寫詞
簡介目錄
Product Code: PMRREP34779

Persistence Market Research has recently released a comprehensive report on the global Tuberculosis Diagnostics Market, providing an in-depth analysis of key market dynamics, including drivers, trends, opportunities, and challenges. This detailed report sheds light on the market structure and growth potential over the forecast period.

Key Insights:

  • Tuberculosis Diagnostics Market Size (2024E): US$2.3 Bn
  • Projected Market Value (2031F): US$3.3 Bn
  • Global Market Growth Rate (CAGR 2024 to 2031): 5.5%

Tuberculosis Diagnostics Market - Report Scope:

Tuberculosis diagnostics encompass a wide range of tests and tools designed to detect and diagnose tuberculosis (TB), one of the world's deadliest infectious diseases. These diagnostics play a crucial role in identifying active and latent TB infections, guiding treatment, and monitoring the spread of the disease. The market is driven by the increasing prevalence of TB, advancements in diagnostic technologies, and growing awareness about early diagnosis and treatment.

Market Growth Drivers:

Several key factors are fueling the growth of the global Tuberculosis Diagnostics Market. The rising incidence of TB in many regions, particularly in developing nations, is a significant driver. Government initiatives aimed at eliminating TB, coupled with funding from global health organizations like the World Health Organization (WHO), are boosting demand for effective diagnostic solutions. Technological advancements, such as molecular diagnostics and point-of-care testing, are also propelling market growth by enabling faster and more accurate detection of the disease. The increasing focus on early detection to prevent the spread of TB is further driving the adoption of advanced diagnostic tools.

Market Restraints:

Despite the growth potential, the Tuberculosis Diagnostics Market faces certain challenges. One of the primary restraints is the high cost of advanced diagnostic technologies, which can be prohibitive in low- and middle-income countries where TB is most prevalent. Additionally, the lack of access to healthcare facilities and diagnostic infrastructure in rural and underdeveloped regions poses a barrier to market growth. The complexity of TB diagnostics and the need for trained healthcare professionals to administer tests and interpret results can further limit adoption in resource-constrained settings.

Market Opportunities:

The Tuberculosis Diagnostics Market offers substantial growth opportunities, particularly with ongoing innovations in diagnostic tools and technologies. The development of cost-effective, portable, and user-friendly diagnostic devices presents a significant opportunity for market expansion in underserved regions. The increasing adoption of digital health solutions and telemedicine for remote TB diagnosis and monitoring can also drive market growth. Strategic collaborations between diagnostic companies and healthcare organizations are expected to enhance research and development, further advancing the capabilities of TB diagnostics.

Key Questions Answered in the Report:

  • What are the primary factors driving the global Tuberculosis Diagnostics Market?
  • Which regions and healthcare systems are experiencing the highest demand for TB diagnostic tools?
  • How are technological innovations influencing the market landscape for TB diagnostics?
  • Who are the leading players in the Tuberculosis Diagnostics Market, and what strategies are they adopting to stay competitive?
  • What are the emerging trends and future growth prospects in the global TB diagnostics market?

Competitive Intelligence and Business Strategy:

Leading players in the Tuberculosis Diagnostics Market, including companies like Cepheid, BD (Becton, Dickinson and Company), and Abbott Laboratories, are focusing on innovation, research and development, and strategic collaborations to strengthen their market positions. These companies are investing in the development of advanced molecular diagnostic tools and rapid testing kits that provide faster and more accurate results. Partnerships with healthcare providers and governmental health agencies are key for market penetration and addressing the global TB burden. Additionally, these companies are striving to reduce the cost of diagnostics and improve accessibility in low-resource settings, which is crucial for long-term success in the Tuberculosis Diagnostics Market.

Key Companies Profiled:

  • Abbott
  • QIAGEN
  • Thermo Fisher Scientific Inc.
  • BD
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • Cepheid
  • DiaSorin S.p.A.
  • Hain Lifescience GmbH
  • Oxford Immunotec

Market Segmentation

By Test Type

  • Nucleic Acid Testing
  • SMEAR Microscopy
  • Radiography Tests

By End User

  • Hospitals & Clinics
  • Diagnostics Centres

By Region

  • North America
  • Latin America
  • Europe
  • South Asia & Oceania
  • East Asia
  • The Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Tuberculosis Diagnostics Market Snapshot, 2024-2031
  • 1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global GDP Growth Outlook
    • 2.3.2. Global Healthcare Spending Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Disease Epidemiology
  • 3.3. Regulatory Landscape
  • 3.4. Value Chain Analysis
  • 3.5. Key Deals and Mergers
  • 3.6. PESTLE Analysis
  • 3.7. Porter's Five Force Analysis

4. Global Tuberculosis Diagnostics Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 4.1. Global Tuberculosis Diagnostics Market Outlook: Test Type
    • 4.1.1. Introduction / Key Findings
    • 4.1.2. Historical Market Size (US$ Bn) Analysis, By Test Type, 2019-2023
    • 4.1.3. Current Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2024-2031
      • 4.1.3.1. Nucleic Acid Testing
      • 4.1.3.2. SMEAR Microscopy
      • 4.1.3.3. Radiography Tests
  • 4.2. Market Attractiveness Analysis: Test Type
  • 4.3. Global Tuberculosis Diagnostics Market Outlook: End-user
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Bn) Analysis, By End-user, 2019-2023
    • 4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2024-2031
      • 4.3.3.1. Hospitals & Clinics
      • 4.3.3.2. Diagnostics Centres
  • 4.4. Market Attractiveness Analysis: End-user

5. Global Tuberculosis Diagnostics Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2023
  • 5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2024-2031
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Tuberculosis Diagnostics Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 6.1. Key Highlights
  • 6.2. Pricing Analysis
  • 6.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
    • 6.3.1. By Country
    • 6.3.2. By Product
    • 6.3.3. By End User
  • 6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 6.4.1. U.S.
    • 6.4.2. Canada
  • 6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
    • 6.5.1. Nucleic Acid Testing
    • 6.5.2. SMEAR Microscopy
    • 6.5.3. Radiography Tests
  • 6.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
    • 6.6.1. Hospitals & Clinics
    • 6.6.2. Diagnostics Centres
  • 6.7. Market Attractiveness Analysis

7. Europe Tuberculosis Diagnostics Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
    • 7.3.1. By Country
    • 7.3.2. By Product
    • 7.3.3. By End User
  • 7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 7.4.1. Germany
    • 7.4.2. France
    • 7.4.3. U.K.
    • 7.4.4. Italy
    • 7.4.5. Spain
    • 7.4.6. Russia
    • 7.4.7. Turkey
    • 7.4.8. Rest of Europe
  • 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
    • 7.5.1. Nucleic Acid Testing
    • 7.5.2. SMEAR Microscopy
    • 7.5.3. Radiography Tests
  • 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
    • 7.6.1. Hospitals & Clinics
    • 7.6.2. Diagnostics Centres
  • 7.7. Market Attractiveness Analysis

8. East Asia Tuberculosis Diagnostics Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
    • 8.3.1. By Country
    • 8.3.2. By Product
    • 8.3.3. By End User
  • 8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 8.4.1. China
    • 8.4.2. Japan
    • 8.4.3. South Korea
  • 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
    • 8.5.1. Nucleic Acid Testing
    • 8.5.2. SMEAR Microscopy
    • 8.5.3. Radiography Tests
  • 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
    • 8.6.1. Hospitals & Clinics
    • 8.6.2. Diagnostics Centres
  • 8.7. Market Attractiveness Analysis

9. South Asia & Oceania Tuberculosis Diagnostics Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
    • 9.3.1. By Country
    • 9.3.2. By Product
    • 9.3.3. By End User
  • 9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 9.4.1. India
    • 9.4.2. Southeast Asia
    • 9.4.3. ANZ
    • 9.4.4. Rest of South Asia & Oceania
  • 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
    • 9.5.1. Nucleic Acid Testing
    • 9.5.2. SMEAR Microscopy
    • 9.5.3. Radiography Tests
  • 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
    • 9.6.1. Hospitals & Clinics
    • 9.6.2. Diagnostics Centres
  • 9.7. Market Attractiveness Analysis

10. Latin America Tuberculosis Diagnostics Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
    • 10.3.1. By Country
    • 10.3.2. By Product
    • 10.3.3. By End User
  • 10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 10.4.1. Brazil
    • 10.4.2. Mexico
    • 10.4.3. Rest of Latin America
  • 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
    • 10.5.1. Nucleic Acid Testing
    • 10.5.2. SMEAR Microscopy
    • 10.5.3. Radiography Tests
  • 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
    • 10.6.1. Hospitals & Clinics
    • 10.6.2. Diagnostics Centres
  • 10.7. Market Attractiveness Analysis

11. Middle East & Africa Tuberculosis Diagnostics Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 11.1. Key Highlights
  • 11.2. Pricing Analysis
  • 11.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
    • 11.3.1. By Country
    • 11.3.2. By Product
    • 11.3.3. By End User
  • 11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 11.4.1. GCC Countries
    • 11.4.2. Egypt
    • 11.4.3. South Africa
    • 11.4.4. Northern Africa
    • 11.4.5. Rest of Middle East & Africa
  • 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
    • 11.5.1. Nucleic Acid Testing
    • 11.5.2. SMEAR Microscopy
    • 11.5.3. Radiography Tests
  • 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
    • 11.6.1. Hospitals & Clinics
    • 11.6.2. Diagnostics Centres
  • 11.7. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Abbott
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Products
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. QIAGEN
    • 12.3.3. Thermo Fisher Scientific Inc.
    • 12.3.4. BD
    • 12.3.5. F. Hoffmann-La Roche AG
    • 12.3.6. Hologic, Inc.
    • 12.3.7. Cepheid
    • 12.3.8. DiaSorin S.p.A.
    • 12.3.9. Hain Lifescience GmbH
    • 12.3.10. Oxford Immunotec
    • 12.3.11. Others

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations